Literature DB >> 25451944

Genome annotation by shotgun inactivation of a native gene in hemizygous cells: application to BRCA2 with implication of hypomorphic variants.

Soma Ghosh1, Anil K Bhunia, Bogdan C Paun, Samuel F Gilbert, Urmil Dhru, Kalpesh Patel, Scott E Kern.   

Abstract

The greatest interpretive challenge of modern medicine may be to functionally annotate the vast variation of human genomes. Demonstrating a proposed approach, we created a library of BRCA2 exon 27 shotgun-mutant plasmids including solitary and multiplex mutations to generate human knockin clones using homologous recombination. This 55-mutation, 13-clone syngeneic variance library (SyVaL) comprised severely affected clones having early-stop nonsense mutations, functionally hypomorphic clones having multiple missense mutations emphasizing the potential to identify and assess hypomorphic mutations in novel proteomic and epidemiologic studies, and neutral clones having multiple missense mutations. Efficient coverage of nonessential amino acids was provided by mutation multiplexing. Severe mutations were distinguished from hypomorphic or neutral changes by chemosensitivity assays (hypersensitivity to mitomycin C and acetaldehyde), by analysis of RAD51 focus formation, and by mitotic multipolarity. A multiplex unbiased approach of generating all-human SyVaLs in medically important genes, with random mutations in native genes, would provide databases of variants that could be functionally annotated without concerns arising from exogenous cDNA constructs or interspecies interactions, as a basis for subsequent proteomic domain mapping or clinical calibration if desired. Such gene-irrelevant approaches could be scaled up for multiple genes of clinical interest, providing distributable cellular libraries linked to public-shared functional databases.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  BRCA2; homologous recombination; hypomorphs; shotgun library

Mesh:

Substances:

Year:  2015        PMID: 25451944      PMCID: PMC4492117          DOI: 10.1002/humu.22736

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  34 in total

1.  Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

Authors:  David E Goldgar; Douglas F Easton; Amie M Deffenbaugh; Alvaro N A Monteiro; Sean V Tavtigian; Fergus J Couch
Journal:  Am J Hum Genet       Date:  2004-08-02       Impact factor: 11.025

2.  Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.

Authors:  Kangjian Wu; Shannon R Hinson; Akihiro Ohashi; Daniel Farrugia; Patricia Wendt; Sean V Tavtigian; Amie Deffenbaugh; David Goldgar; Fergus J Couch
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

3.  Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive media.

Authors:  Jonathan R Brody; Eric S Calhoun; Eike Gallmeier; Talisa D Creavalle; Scott E Kern
Journal:  Biotechniques       Date:  2004-10       Impact factor: 1.993

Review 4.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

5.  In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.

Authors:  Michiel S van der Heijden; Jonathan R Brody; David A Dezentje; Eike Gallmeier; Steven C Cunningham; Michael J Swartz; Angelo M DeMarzo; G Johan A Offerhaus; William H Isacoff; Ralph H Hruban; Scott E Kern
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

6.  Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.

Authors:  Eike Gallmeier; Eric S Calhoun; Carlo Rago; Jonathan R Brody; Steven C Cunningham; Tomas Hucl; Myriam Gorospe; Manu Kohli; Christoph Lengauer; Scott E Kern
Journal:  Gastroenterology       Date:  2006-06       Impact factor: 22.682

Review 7.  Tetraploidy, aneuploidy and cancer.

Authors:  Neil J Ganem; Zuzana Storchova; David Pellman
Journal:  Curr Opin Genet Dev       Date:  2007-02-26       Impact factor: 5.578

8.  Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.

Authors:  Matthew J Daniels; Yunmei Wang; Miyoung Lee; Ashok R Venkitaraman
Journal:  Science       Date:  2004-09-16       Impact factor: 47.728

9.  CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.

Authors:  Fumiko Esashi; Nicole Christ; Julian Gannon; Yilun Liu; Tim Hunt; Maria Jasin; Stephen C West
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

10.  Improved methods for the generation of human gene knockout and knockin cell lines.

Authors:  Ozlem Topaloglu; Paula J Hurley; Ozlem Yildirim; Curt I Civin; Fred Bunz
Journal:  Nucleic Acids Res       Date:  2005-10-07       Impact factor: 16.971

View more
  1 in total

1.  WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.

Authors:  Shruti Lal; Mahsa Zarei; Saswati N Chand; Emanuela Dylgjeri; Nicole C Mambelli-Lisboa; Michael J Pishvaian; Charles J Yeo; Jordan M Winter; Jonathan R Brody
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.